Home Programme Participating companies About Kempen Registration Location Contact
                 
         
                 
  • Belgium
  • Sector: Antibodies
  • Capitalisation: €222m
  • Presentation
      
  • The Netherlands
  • Sector: Gene therapy
  • Capitalisation: €160m
   
  • Switzerland
  • Sector: Antibiotics
  • Capitalisation: CFH306m
  • Presentation
     
     
           
                 
  • The Netherlands
  • Sector: Infectious diseases
  • Capitalisation: €645m
  • Presentation

 

            
  • The Netherlands
  • Sector: Allergen & medical products
  • Capitalisation: €131m
  • Presentation
     
     
           
                 
  • Belgium
  • Sector: Drug discovery
  • Capitalisation: €144m
  • Presentation
      
  • Austria
  • Sector: Infectious diseases
  • Capitalisation: €1,164m
  • Presentation
      
  • Germany
  • Sector: Antibodies
  • Capitalisation: €328m
  • Presentation
     
     
           
                 
  • Belgium
  • Sector: Molecular diagnostics
  • Capitalisation: €104m
  • Presentation
      
  • The Netherlands
  • Sector: Therapeuticproteins
  • Capitalisation: €108m
  • Presentation
      
  • Belgium
  • Sector: Cardiovascular
  • Capitalisation: €204m
  • Presentation